PMID- 30356026 OWN - NLM STAT- MEDLINE DCOM- 20190115 LR - 20190115 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 19 IP - 11 DP - 2018 Oct 24 TI - Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes. LID - 10.3390/ijms19113313 [doi] LID - 3313 AB - Brain-derived neurotrophic factor (BDNF) is a key molecule essential for neural plasticity and development, and is implicated in the pathophysiology of various central nervous system (CNS) disorders. It is now documented that BDNF is synthesized not only in neurons, but also in astrocytes which actively regulate neuronal activities by forming tripartite synapses. Inwardly rectifying potassium (Kir) channel subunit Kir4.1, which is specifically expressed in astrocytes, constructs Kir4.1 and Kir4.1/5.1 channels, and mediates the spatial potassium (K(+)) buffering action of astrocytes. Recent evidence illustrates that Kir4.1 channels play important roles in bringing about the actions of antidepressant drugs and modulating BDNF expression in astrocytes. Although the precise mechanisms remain to be clarified, it seems likely that inhibition (down-regulation or blockade) of astrocytic Kir4.1 channels attenuates K(+) buffering, increases neuronal excitability by elevating extracellular K(+) and glutamate, and facilitates BDNF expression. Conversely, activation (up-regulation or opening) of Kir4.1 channels reduces neuronal excitability by lowering extracellular K(+) and glutamate, and attenuates BDNF expression. Particularly, the former pathophysiological alterations seem to be important in epileptogenesis and pain sensitization, and the latter in the pathogenesis of depressive disorders. In this article, we review the functions of Kir4.1 channels, with a focus on their regulation of spatial K(+) buffering and BDNF expression in astrocytes, and discuss the role of the astrocytic Kir4.1-BDNF system in modulating CNS disorders. FAU - Ohno, Yukihiro AU - Ohno Y AD - Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. yohno@gly.oups.ac.jp. FAU - Kinboshi, Masato AU - Kinboshi M AD - Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. kinboshi@kuhp.kyoto-u.ac.jp. FAU - Shimizu, Saki AU - Shimizu S AD - Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. s.shimizu@gly.oups.ac.jp. LA - eng GR - 17K08324/Ministry of Education, Culture, Sports, Science and Technology/ GR - 15H04892/Ministry of Education, Culture, Sports, Science and Technology/ GR - 16K21501/Ministry of Education, Culture, Sports, Science and Technology/ PT - Journal Article PT - Review DEP - 20181024 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Kcnj10 (channel)) RN - 0 (Potassium Channels, Inwardly Rectifying) SB - IM MH - Animals MH - Astrocytes/*metabolism MH - Brain-Derived Neurotrophic Factor/*genetics/metabolism MH - Depressive Disorder/*metabolism MH - Epilepsy/*metabolism MH - Humans MH - Neurons/metabolism/physiology MH - Potassium Channels, Inwardly Rectifying/chemistry/genetics/*metabolism PMC - PMC6274740 OTO - NOTNLM OT - Kir4.1 channels OT - astrocytes OT - brain-derived neurotrophic factor (BDNF), depressive disorders OT - epilepsy OT - pain OT - spatial potassium buffering COIS- The authors declare no conflict of interest. EDAT- 2018/10/26 06:00 MHDA- 2019/01/16 06:00 PMCR- 2018/11/01 CRDT- 2018/10/26 06:00 PHST- 2018/09/24 00:00 [received] PHST- 2018/10/19 00:00 [revised] PHST- 2018/10/22 00:00 [accepted] PHST- 2018/10/26 06:00 [entrez] PHST- 2018/10/26 06:00 [pubmed] PHST- 2019/01/16 06:00 [medline] PHST- 2018/11/01 00:00 [pmc-release] AID - ijms19113313 [pii] AID - ijms-19-03313 [pii] AID - 10.3390/ijms19113313 [doi] PST - epublish SO - Int J Mol Sci. 2018 Oct 24;19(11):3313. doi: 10.3390/ijms19113313.